Your browser doesn't support javascript.
loading
SYK is activated by mutated MYD88 and drives pro-survival signaling in MYD88 driven B-cell lymphomas.
Munshi, Manit; Liu, Xia; Chen, Jiaji G; Xu, Lian; Tsakmaklis, Nickolas; Demos, Maria G; Kofides, Amanda; Guerrera, Maria Luisa; Jimenez, Cristina; Chan, Gloria G; Hunter, Zachary R; Palomba, M Lia; Argyropoulos, Kimon V; Meid, Kirsten; Keezer, Andrew; Gustine, Joshua; Dubeau, Toni; Castillo, Jorge J; Patterson, Christopher J; Wang, Jinhua; Buhrlage, Sara J; Gray, Nathanael S; Treon, Steven P; Yang, Guang.
Afiliação
  • Munshi M; Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Liu X; Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Chen JG; Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Xu L; Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Tsakmaklis N; Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Demos MG; Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Kofides A; Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Guerrera ML; Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Jimenez C; Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Chan GG; Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Hunter ZR; Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Palomba ML; Department of Medical Oncology, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Argyropoulos KV; Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Meid K; Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Keezer A; Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Gustine J; Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Dubeau T; Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Castillo JJ; Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Patterson CJ; Department of Medical Oncology, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Wang J; Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Buhrlage SJ; Department of Medical Oncology, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Gray NS; Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Treon SP; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
  • Yang G; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
Blood Cancer J ; 10(1): 12, 2020 01 31.
Article em En | MEDLINE | ID: mdl-32005797

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B / Fator 88 de Diferenciação Mieloide / Quinase Syk Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Blood Cancer J Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B / Fator 88 de Diferenciação Mieloide / Quinase Syk Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Blood Cancer J Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos